<DOC>
	<DOCNO>NCT00080496</DOCNO>
	<brief_summary>To compare efficacy safety tigecycline regimen imipenem/cilastatin regimen subject nosocomial pneumonia .</brief_summary>
	<brief_title>Study Evaluating Tigecycline Versus Imipenem/Cilastatin Hospital-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Male female subject 18 year age . Bulgaria Only : Male female subject 18 year age 70 year age . Subjects know suspected acute hospitalacquired pneumonia . Presence follow pulmonary condition : cystic fibrosis ; pulmonary malignancy ( either primary metastatic ) ; know bronchialobstructive post obstructive pneumonia ; pulmonary abscess ; empyema ; know suspect active tuberculosis ; bronchiectasis ; sarcoidosis ; know suspect pulmonary infection cause Pneumocystis carinii , mycobacteria , fungi , parasite , virus ( Subjects COPD exclude ) Suspected know Legionella infection Concurrent hemodialysis , hemofiltration , peritoneal dialysis , plasmapheresis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Pneumonia</keyword>
</DOC>